Results 41 to 50 of about 1,210 (152)

Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD

Liver International, Volume 45, Issue 2, February 2025.
ABSTRACT Background and Aims The performance of non‐invasive liver tests (NITs) is known to vary across settings and subgroups. We systematically evaluated whether the performance of three NITs in detecting advanced fibrosis in patients with metabolic dysfunction‐associated steatotic liver disease (MASLD) varies with age, sex, body mass index (BMI ...
Yasaman Vali, Anne‐Marieke van Dijk, Jenny Lee, Jerome Boursier, Vlad Ratziu, Carla Yunis, Jörn M. Schattenberg, Luca Valenti, Manuel Romero Gomez, Detlef Schuppan, Salvatore Petta, Mike Allison, Mark L. Hartman, Kimmo Porthan, Jean‐Francois Dufour, Elisabetta Bugianesi, Amalia Gastadelli, Zoltan Derdak, Celine Fournier‐Poizat, Elizabeth Shumbayawonda, Michael Kalutkiewicz, Hannele Yki‐Jarvinen, Mattias Ekstedt, Andreas Geier, Aldo Trylesinski, Sven Francque, Clifford Brass, Michael Pavlides, Adriaan G. Holleboom, Max Nieuwdorp, Quentin M. Anstee, Patrick M. Bossuyt, the LITMUS investigators   +32 more
wiley   +1 more source

INTEGRITAS SISWA SEKOLAH MENENGAH ATAS DI KAWASAN TIMUR INDONESIA (Pengaruh Tingkat Kondusifitas Lingkungan Terhadap Integritas Siswa)

Al-Qalam, 2019
Penelitian ini bertujuan untuk mengukur tingkat integritas siswa SLTA di 12 provinsi Kawasan Timur Indonesia dalam empat dimensi, yaitu kejujuran, tanggung jawab, toleransi, dan cinta tanah air.
Badruzzaman Badruzzaman
doaj   +1 more source

Peran Optimisme dan Dukungan Sosial terhadap Integritas Ego pada Lanjut Usia

Psikologika: Jurnal Pemikiran dan Penelitian Psikologi, 2020
Pada usia lanjut, individu mengalami perubahan pada seluruh aspek perkembangan. Salah satu yang berpengaruh pada perkembangan psikososial lanjut usia adalah integritas ego.
Alfi Purnamasari, Ismira Dewi
doaj   +1 more source

The Past, Present and Future of Structural Health Monitoring: An Overview of Three Ages

Strain, Volume 61, Issue 1, February 2025.
ABSTRACT This paper presents an overview of the discipline of structural health monitoring (SHM), organised in terms of three proposed ages. The first age is delineated by the prehistory of SHM and the period where nondestructing testing methods evolved into an organised set of principles built upon physics‐based models; this age ended when the model ...
C. R. Farrar, N. Dervilis, K. Worden
wiley   +1 more source

Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH—An individual participant data meta‐analysis

Liver International, Volume 44, Issue 8, Page 1872-1885, August 2024.
Abstract Background & Aims There is a need to reduce the screen failure rate (SFR) in metabolic dysfunction‐associated steatohepatitis (MASH) clinical trials (MASH+F2‐3; MASH+F4) and identify people with high‐risk MASH (MASH+F2‐4) in clinical practice.
Ferenc E. Mózes, Jenny A. Lee, Yasaman Vali, Emmanuel A. Selvaraj, Arjun N. A. Jayaswal, Jérôme Boursier, Victor de Lédinghen, Monica Lupșor‐Platon, Yusuf Yilmaz, Wah‐Kheong Chan, Sanjiv Mahadeva, Thomas Karlas, Johannes Wiegand, Shalimar, Emmanouil Tsochatzis, Antonio Liguori, Vincent Wai‐Sun Wong, Dae Ho Lee, Adriaan G. Holleboom, Anne‐Marieke van Dijk, Anne Linde Mak, Hannes Hagström, Camilla Akbari, Masashi Hirooka, Dong Hyeon Lee, Won Kim, Takeshi Okanoue, Toshihide Shima, Atsushi Nakajima, Masato Yoneda, Paul J. Thuluvath, Feng Li, Annalisa Berzigotti, Yuly P. Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier‐Poizat, Andreas Geier, Theresa Tuthill, Carla Yunis, Quentin M. Anstee, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides   +43 more
wiley   +1 more source

How effective are experienced hepatologists at staging fibrosis using non‐invasive fibrosis tests in patients with metabolic dysfunction‐associated steatotic liver disease?

Alimentary Pharmacology &Therapeutics, Volume 60, Issue 2, Page 267-273, July 2024.
Six experienced hepatologists independently staged 230 MASLD patients for advanced fibrosis (F0‐2 vs. F3‐4) using non‐invasive fibrosis tests (NIT) combinations. When compared with histology, there was variability is accuracy, sensitivity and specificity for F3‐4 between hepatologists.
Stuart McPherson, Jessica K. Dyson, Laura Jopson, Steven Masson, Preya Patel, Quentin M. Anstee   +5 more
wiley   +1 more source

Az adatvédelem, az információszabadság és az integritás összefüggései [PDF]

HatályosítottA tananyag az adatvédelem, az információszabadság és az integritás összefüggéseire fókuszálva segíti az integritás alapú szervezeti működés kialakítását.
Buzás, Péter, Révész, Balázs
core   +2 more sources

Perbandingan Pengencer Tris Kuning Telur dan Susu Skim Kuning Telur Terhadap Persentase Motilitas, Viabilitas dan Integritas Membran Plasma Spermatozoa Kambing Sapera pada Penyimpanan Suhu 5ºC

Jurnal Medik Veteriner, 2020
Penelitian ini bertujuan untuk mengetahui perbedaan pengencer tris kuning telur dan susu skim kuning telur terhadap persentase motilitas, viabilitas dan integritas membran plasma spermatozoa kambing Sapera.
Novia Nur Iskandari, Sri Pantja Madyawati, Prima Ayu Wibawati, Tri Wahyu Suprayogi, Ragil Angga Prastiya, Bodhi Agustono   +5 more
doaj   +1 more source

Analisis Yuridis Kedudukan Kejaksaan Republik Indonesia Dalam Ketatanegaraan Indonesia

Ikatan Penulis Mahasiswa Hukum Indonesian Law Journal, 2021
Kejaksaan Republik Indonesia merupakan salah satu lembaga penegak hukum di Indonesia yang memiliki peran sangat penting yaitu di bidang penuntutan. Sebagai lembaga penegak hukum, kejaksaan diharapkan mampu bersikap adil dan profesional sesuai dengan ...
Saeful Bahri
doaj   +1 more source

Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis

Alimentary Pharmacology &Therapeutics, Volume 59, Issue 1, Page 51-63, January 2024.
Summary Background Non‐alcoholic steatohepatitis (NASH) is a progressive form of non‐alcoholic fatty liver disease (NAFLD) associated with steatosis, hepatocellular injury, inflammation and fibrosis. In a Phase 2 trial in adults with NASH (NCT02912260), resmetirom, an orally administered, liver‐targeted thyroid hormone receptor‐β selective agonist ...
Stephen A. Harrison, Vlad Ratziu, Quentin M. Anstee, Mazen Noureddin, Arun J. Sanyal, Jörn M. Schattenberg, Pierre Bedossa, Mustafa R. Bashir, David Schneider, Rebecca Taub, Meena Bansal, Kris V. Kowdley, Zobair M. Younossi, Rohit Loomba   +13 more
wiley   +1 more source